Why Is Wegovy Cheaper Than Mounjaro in the UK? Complete Pricing Breakdown

The Price Gap: Mounjaro's Recent Price Surge

As of September 1, 2025, Mounjaro (tirzepatide) became significantly more expensive than Wegovy (semaglutide) in the UK, creating a major cost disparity that didn't exist previously.​

Current UK Private Pricing:

• Wegovy: £99-£229/month depending on dose​
  
  
• Mounjaro: £289-£384/month for maintenance doses​
  
  

This represents a 40-65% price increase for Mounjaro since September 2025.​

Why Mounjaro Prices Increased So Dramatically

Eli Lilly's Manufacturer Price Adjustment (September 2025):

Mounjaro's price surge resulted from Eli Lilly, the manufacturer, aligning UK wholesale prices with US and European markets. Previously, UK pricing was artificially low due to historical regional pricing strategies. This change affects all UK healthcare providers—NHS and private.​

Specific price increases per dose:​

• 2.5mg: Rose from £191 to £354.10 (85% increase)
  
  
• 15mg: Rose from £191 to £384.20 (101% increase)​
  
  

Contrast with Wegovy: Semaglutide prices have remained relatively stable, with some providers even reducing prices to remain competitive.​

Supply & Demand Dynamics

Wegovy has experienced more supply issues globally, which paradoxically kept UK pricing lower as competition for available stock drove down prices. Conversely, Mounjaro's stronger UK supply position allowed the manufacturer to implement the full price adjustment without concern for market share loss.​

Clinical Efficacy Doesn't Justify the Price Premium

While Mounjaro achieves slightly higher average weight loss (20-22%) versus Wegovy (15-21%), this modest clinical advantage does not justify the 40% price premium.​

Cost-per-kilogram-lost analysis:

• Wegovy: Lower cost per kg lost
  
  
• Mounjaro: Significantly higher cost per kg lost despite marginal additional benefit​
  
  

For most patients, the difference between 20% and 22% weight loss is clinically insignificant, making Wegovy the more cost-effective choice.​

NHS Access Differences (Irrelevant to Price, But Important for Context)

On the NHS:

• Wegovy: Limited access; primarily for patients with BMI ≥35 + one comorbidity​
  
  
• Mounjaro: Expanding rollout; estimated NHS cost £122/month at maintenance dose​
  
  

However, 95% of UK users pay privately, making NHS differences moot for pricing discussions.​

Why Some Patients Still Choose Mounjaro

Despite higher costs, Mounjaro remains attractive because:​

• Slightly higher average weight loss (20-22% vs. 15-21%)
  
  
• More dose options (six doses vs. five for Wegovy) allowing better individualization
  
  
• Better tolerability for some patients (fewer GI side effects reported)
  
  
• Established track record and provider familiarity
  
  

The Bottom Line: Wegovy Now Dominates on Value

Post-September 2025, Wegovy is the clear cost winner:

• Annual cost: £1,188-£2,748 vs. Mounjaro's £3,468-£4,608​
  
  
• Annual savings with Wegovy: £1,200-£2,000​
  
  

Unless a patient demonstrates significantly better response to Mounjaro or intolerance to Wegovy, the price differential makes Wegovy the rational choice for UK patients.​

Practical Recommendation

Switch to Wegovy if:

• Currently on Mounjaro but concerned about rising costs​
  
  
• Achieving adequate weight loss (>3% at 6 months)
  
  
• No specific tolerability issues with semaglutide
  
  

Stay with Mounjaro if:

• Mounjaro provides meaningfully better results for you personally
  
  
• You've experienced Wegovy side effects
  
  
• Cost is not a primary concern
  
  

The September 2025 price increase fundamentally shifted the cost-benefit analysis, making Wegovy the more affordable and pragmatic choice for most UK weight loss patients.​

1. https://drugs4delivery.com/mounjaro-and-wegovy-price-changes-coming-september-2025/
2. https://www.joinvoy.com/blog/mounjaro-price-increase
3. https://www.healthexpress.co.uk/mounjaro-price-increase-wegovy-switch
4. https://www.boltpharmacy.co.uk/guide/mounjaro-vs-wegovy-cost
5. https://sloanestreetsurgery.co.uk/articles/mounjaro-price-increase-what-it-means-and-how-to-switch-to-wegovy/
6. https://www.diabetes.org.uk/about-us/news-and-views/our-response-serious-supply-issues-drugs-people-living-type-2-diabetes
7. https://www.medexpress.co.uk/landing/weight-loss/price-explainer
8. https://onlinedoctor.superdrug.com/weight-loss-injections-on-the-nhs.html
9. https://www.healthpolicypartnership.com/are-weight-loss-treatments-contributing-to-health-inequalities/
10. https://nettlespharmacy.com/mounjaro-price-comparison-uk/
11. https://onlinedoctor.asda.com/uk/wegovy-vs-mounjaro-vs-ozempic.html
12. https://www.boltpharmacy.co.uk/guide/mounjaro-vs-ozempic-cost-uk
13. https://livewellweightloss.co.uk/mounjaro-pen-price-comparison-uk-2025/
14. https://www.theindependentpharmacy.co.uk/weight-loss/guides/mounjaro-vs-wegovy-how-do-they-compare
15. https://www.cheshireandmerseyside.nhs.uk/your-health/prescribing/statements/mounjaro-tirzepatide/
16. https://www.slimtransformation.co.uk/post/how-do-the-costs-of-wegovy-and-mounjaro-compare
17. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/behind-the-headlines/mounjaro-vs-wegovy
18. https://www.kingsfund.org.uk/insight-and-analysis/blogs/glp-1-drugs-nhs-should-roll-them-out-at-scale
19. https://www.numan.com/weight-loss/medication/price-changes-mounjaro
20. https://www.simpleonlinepharmacy.co.uk/health-advice/weight-loss/options-cant-afford-mounjaro/

‍